GMEB1

Across TCGA pan-cancer cohorts, GMEB1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GMEB1 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher GMEB1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated GMEB1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

LUAD, CCRCC, and HNSC are the cancer types where GMEB1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.911	0.303	.001	20	view →
CCRCC	OS	Median	All	0.899	0.794	.029	2	view →
HNSC	DFS	Median	III,IV	0.939	1.000	.043	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GMEB1–LUAD (OS)

Open the LUAD breakdown →